[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356530-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356530-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","marine-trichodermamide-b-inhibits-prostate-cancer-progression-via-catalase-inhibition-induced-apoptosis","Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis","","Prostate cancer often develops resistance to conventional therapies, making new targets essential. Catalase maintains cellular redox homeostasis; its inhibition disrupts oxidative balance, triggering oxidative stress and cell death. This study evaluates trichodermamide B as an anticancer agent by investigating how it induces catalase-related apoptosis in prostate cancer cells, combining cellular assays, mechanistic analyses, docking, and validation across 2D and 3D and in vivo xenograft models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/marine-trichodermamide-b-inhibits-prostate-cancer-progression-via-catalase-inhibition-induced-apoptosis/356530/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/marine-trichodermamide-b-inhibits-prostate-cancer-progression-via-catalase-inhibition-induced-apoptosis/356530.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is catalase inhibition considered a promising strategy for prostate cancer?","Question",{"text":63,"@type":64},"Catalase maintains cellular redox homeostasis. Inhibiting catalase disrupts oxidative balance, causing oxidative stress and promoting cell death, supporting catalase as a therapeutic target.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was trichodermamide B evaluated for anti-prostate cancer activity?",{"text":68,"@type":64},"Anti-prostate cancer activity was tested using multiple prostate cancer cell lines (LNCaP, 22Rv1, PC-3, DU145) with viability and clonogenic assays, 3D sphere growth models, flow cytometry for cell cycle arrest and apoptosis, enzymatic activity assays, and docking plus protein-level validations.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanisms did the study propose for trichodermamide B action?",{"text":72,"@type":64},"Trichodermamide B was predicted to bind catalase and was shown to inhibit catalase enzymatic activity, leading to impaired redox homeostasis, ROS accumulation, oxidative stress, and apoptosis. It also modulated androgen receptor (AR) signaling and AR target gene expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356530,1790273717,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Fang et al. Cell Communication and Signaling (2026) 24:192  \n[https://doi.org/10.1186/s12964-026-02737-y](https://doi.org/10.1186/s12964-026-02737-y)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nMarine trichodermamide B inhibits prostate cancer progression via catalase inhibitioninduced apoptosis  \nWenxuan Fang1,2†, Chunmei Chen3†, Mingyi Nie1,2†, Qiuyu Liu1,2, Tianwen Huang1, Chenghai Gao2, Yonghong Liu2,3*, Xuefeng Zhou3* and Xueni Wang1,2*  \nAbstract  \nBackground Prostate cancer, a leading cause of cancer-related mortality in men, often develops resistance to conventional therapies, necessitating the discovery of novel therapeutic targets. Catalase plays a critical role in maintaining cellular redox homeostasis. Its inhibition disrupts oxidative balance, leading to oxidative stress and cell death, which positions catalase as a promising therapeutic target for cancer treatment. This study explores the anticancer effects and mechanisms of action oftrichodermamide B in targeting catalase-induced apoptosis in prostate cancer cells.  \nMethods The anti-prostate cancer activity oftrichodermamide B was evaluated using multiple prostate cancer cell lines, including LNCaP, 22Rv1, PC-3, and DU145 . Cytotoxicity was assessed through cell viability assays, while clonogenic assays were employed to measure the compound's ability to inhibit colony formation. The impact on 3D cell sphere growth was examined using LNCaP-3D models. Flow cytometry was utilized to analyze cell cycle arrest and apoptosis induction. Molecular docking studies were conducted to predict the interaction between trichodermamide B and catalase. The cell-free catalase enzymatic activity assay was employed to detect the inhibitory effect of trichodermamide B on catalase activity in vitro. Proteome profiler human apoptosis array kits and immunoblotting were used to validate the suppression of catalase expression. Additionally, the effects on androgen receptor (AR) activity and AR target genes (KLK3 and TMPRSS2) were investigated by western blot and qPCR. In vivo efficacy was confirmed using zebrafish and mouse xenograft tumor models.  \nResults Trichodermamide B demonstrated potent cytotoxicity against all tested prostate cancer cell lines, with significant inhibition of clonal colony formation in 22Rv1 and PC-3 cells. It also impaired the growth of LNCaP-3D cell spheres, indicating its ability to target both 2D and 3D cancer models. Flow cytometry revealed that trichodermamide  \n†Wenxuan Fang, Chunmei Chen and Mingyi Nie contributed equally to this work.  \n*Correspondence: Yonghong Liu [yonghongliu@scsio.ac.cn](yonghongliu@scsio.ac.cn)[ ](yonghongliu@scsio.ac.cn)Xuefeng Zhou [xfzhou@scsio.ac.cn](xfzhou@scsio.ac.cn)  \nXueni Wang [wangxueni@gxtcmu.edu.cn](wangxueni@gxtcmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nFang et al. Cell Communication and Signaling (2026) 24:192 Page 2 of 21  \nB induced cell cycle arrest and apoptosis. Molecular docking studies predicted a s","cbCaitMMflAMPSF9","https://ap.wps.com/l/cbCaitMMflAMPSF9","pdf",21492800,21,"English","# Abstract\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"Why is catalase inhibition considered a promising strategy for prostate cancer?\",\"answer\":\"Catalase maintains cellular redox homeostasis. Inhibiting catalase disrupts oxidative balance, causing oxidative stress and promoting cell death, supporting catalase as a therapeutic target.\"},{\"question\":\"How was trichodermamide B evaluated for anti-prostate cancer activity?\",\"answer\":\"Anti-prostate cancer activity was tested using multiple prostate cancer cell lines (LNCaP, 22Rv1, PC-3, DU145) with viability and clonogenic assays, 3D sphere growth models, flow cytometry for cell cycle arrest and apoptosis, enzymatic activity assays, and docking plus protein-level validations.\"},{\"question\":\"What mechanisms did the study propose for trichodermamide B action?\",\"answer\":\"Trichodermamide B was predicted to bind catalase and was shown to inhibit catalase enzymatic activity, leading to impaired redox homeostasis, ROS accumulation, oxidative stress, and apoptosis. It also modulated androgen receptor (AR) signaling and AR target gene expression.\"}]","Marine trichodermamide B inhibits prostate cancer progression via catalase inhibition-induced apoptosis | PDF",1790125856,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b18aab6406401166c76594feeb057e85.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0e8086014f161b980a00b2b22d9e5d0.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0662da4a2f1a52d90210529ff9300256.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf9816b0f2b4d31536d334306f384172.webp",980,1306]